|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.10 EUR | +3.43% |
|
+8.38% | +21.48% |
| 30/06 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 16/06 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZAI LAB LIMITED | Biopharmaceuticals | +3.43% | +8.38% | - | - | - | 230.22Cr |
-
|
-
|
-
|
- Stock Market
- Stocks
- ZLAB Stock
- 1ZL Stock
- Charts Zai Lab Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















